Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024043
Filing Date
2024-09-27
Accepted
2024-09-27 16:21:15
Documents
1
Period of Report
2024-04-17

Document Format Files

Seq Description Document Type Size
1 form4-09272024_080911.html 4  
1 form4-09272024_080911.xml 4 6950
  Complete submission text file 0001415889-24-024043.txt   8320
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address
Hemrajani Rekha (Reporting) CIK: 0001771213 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42279 | Film No.: 241335158